Coca-Cola were bought by Coca-Cola in 1953. In 1885, Pemberton registered his French Wine Coca nerve tonic. In 1886, when Atlanta and Fulton County passed prohibition legislation, Pemberton responded by developing Coca-Cola, a nonalcoholic version of French Wine Coca. The first sales were at Jacob's Pharmacy in Atlanta, Georgia, on May 8, 1886. It was initially sold as a patent medicine for five cents a glass at soda fountains, which were popular in the United States at the time due to the belief that carbonated water was good for the health. Pemberton claimed Coca-Cola cured many diseases, including morphine addiction, indigestion,
Coca-Cola Enterprises paid over $15 billion, including a redemption of Coca-Cola's 33% shareholding in CCE. Coca-Cola wanted the business in their asset list because they felt it would save both consumers and Coca-Cola money. Coca-Cola also spun off its small European bottling division to "New CCE". The acquisition closed on October 3, 2010. On August 6, 2015, Coca-Cola Enterprises announced that it would merge with Coca-Cola Iberian Partners and Coca-Cola Erfrischungsgetränke AG, a subsidiary of the Coca-Cola Company, into a new company to be called Coca-Cola European Partners PLC. Coca-Cola Enterprises Coca-Cola Enterprises was a marketer, producer, and distributor of Coca-Cola products.